PRMB 8-DAY DEADLINE ALERT: Hagens Berman Scrutinizing Alleged Undisclosed Technology Failures and Supply Chain Risks in Pending Primo Brands (PRMB) Lawsuit
Globenewswire·2026-01-04 17:00

Core Viewpoint - The article discusses a pending securities class action lawsuit against Primo Brands Corporation, highlighting the alleged operational failures following its merger with BlueTriton Brands and the significant losses incurred by investors due to misrepresentations by the company's management [1][2][4]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who suffered after the revelation of a severe operational crisis that was allegedly concealed by the company [2]. - The complaint claims that management assured investors of a "flawless" merger integration, while the reality involved catastrophic failures in technology, logistics, and customer service [2][4]. - The stock price dropped 21% following the announcement of a significant reduction in full-year adjusted EBITDA guidance and the replacement of the CEO on November 6, 2025, indicating a substantial loss of shareholder value [3][7]. Group 2: Allegations of Misrepresentation - The core of the complaint centers on the contradiction between the company's assurances of a successful merger and the new CEO's admission of "self-inflicted" disruptions affecting the ReadyRefresh delivery business [4]. - Allegations include that the accelerated integration process led to severe technology breakdowns, supply disruptions, and major customer service issues, which were not disclosed to investors [7]. - The first disclosure event occurred on August 7, 2025, when the company reported weak Q2 results and reduced guidance, causing a 9% drop in stock price [7]. Group 3: Next Steps for Investors - Investors who purchased PRMB shares during the Class Period (June 17, 2024 – November 6, 2025) and experienced losses are encouraged to contact Hagens Berman for potential participation in the lawsuit [5][6]. - The deadline for investors to move the Court for appointment as lead plaintiff is January 12, 2026 [1][6].